Received Nov 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Suspected vaccination failure; I got the flu; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Flu unspecified (Flu vaccine) for prophylaxis. On an unknown date, the patient received Flu vaccine. On an unknown date, several weeks after receiving Flu vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and influenza (Verbatim: I got the flu). The outcome of the vaccination failure and influenza were not reported. It was unknown if the reporter considered the vaccination failure and influenza to be related to Flu vaccine. The company considered the vaccination failure to be unrelated to Flu vaccine. It was unknown if the company considered the influenza to be related to Flu vaccine. Additional Information: GSK Receipt Date: 29-OCT-2025 This case was reported by a patient via interactive digital media. The patient never used to get the flu shot. Then the doctor told him/her into it. Well weeks later the patient got the flu. The patient being a certified nursing assistant (CNA), that got to thinking, the flu is in the shot. Then covid came along. Well, he/she said no, not getting it. The patient never got covid. The patient took care of people that did. Then the patient done some research and found out that where he/she took hydroxychloroquine (hcq) for lupus it protected him/her from getting it. This case was considered as suspected vaccination failure as details regarding time to onset for flu and laboratory confirmation regarding flu were unknown at the time of reporting. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: A case of Vaccination failure, several weeks after receiving Flu vaccine, in a patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.